|
The Bio21 Institute has strategic relationships with a range of industry tenants ranging from the R&D group of Australia's largest biopharmaceutical company - CSL Pty Ltd, to diverse start-up companies residing in the Institute's Incubator and Business Centre.
Our industry tenants include:
- CSL Pty Ltd's R&D group who are focused on therapeutic discovery
- BioScreen Medical who focus on Microbial Diagnostics
- Bruker Daltronics who focus on Mass Spectrometry
- AI Scientific who focus on peptide technology
- Sienna Cancer Diagnostics who focus on molecular biomarkers for specific tumours
- Patrys Ltd is focused on natural human antibodies against human disease
Back to top |
